AI assistant
Sending…
Cryoport, Inc. — Director's Dealing 2023
Sep 13, 2023
32876_dirs_2023-09-13_ed579f89-39b6-4cdd-a9bb-be3468e20260.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2023-09-12
Reporting Person: Sawicki Mark W (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-12 | Common Stock | M | 1000 | $12.79 | Acquired | 73125 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-09-12 | Stock Option (right to buy) | $12.79 | M | 1000 | Disposed | 2029-04-01 | Common Stock (1000) | Direct |
Footnotes
F1: No Common Stock was sold by the reporting person in connection with the transactions disclosed on this Form 4.
F2: Options vested as part of an option that began vesting on the 1st of each month for forty-eight months beginning May 1, 2019.
More from Cryoport, Inc.
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18